Mcdonald Partners LLC Abb Vie Inc. Transaction History

Mcdonald Partners LLC

$381 Million
Q4 2024

A detailed history of Mcdonald Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mcdonald Partners LLC holds 23,952 shares of ABBV stock, worth $4.62 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

23,952

Previous 22,078 8.49%

Holding current value

$4.62 Million

Previous $4.36 Million 2.36%

% of portfolio

1.12%

Previous 1.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$164.99 - $203.87 $309,191 - $382,052	1,874 Added 8.49%	23,952 $4.26 Million
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $391,905 - $476,797	-2,392 Reduced 9.78%	22,078 $4.36 Million
Q2 2024 Jul 17, 2024	BUY	$154.79 - $180.76 $169,185 - $197,570	1,093 Added 4.68%	24,470 $4.2 Million
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $143,518 - $163,525	898 Added 3.99%	23,377 $4.26 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $13,209 - $14,877	96 Added 0.43%	22,479 $3.48 Million
Q3 2023 Oct 30, 2023	BUY	$133.59 - $154.65 $426,419 - $493,642	3,192 Added 16.63%	22,383 $3.34 Million
Q2 2023 Jul 17, 2023	BUY	$132.51 - $164.9 $230,169 - $286,431	1,737 Added 9.95%	19,191 $2.59 Million
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $99,925 - $115,079	691 Added 4.12%	17,454 $2.78 Million
Q4 2022 Jan 18, 2023	SELL	$138.31 - $165.87 $89,763 - $107,649	-649 Reduced 3.73%	16,763 $0
Q3 2022 Oct 21, 2022	SELL	$134.21 - $153.93 $101,596 - $116,525	-757 Reduced 4.17%	17,412 $2.34 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $52,433 - $66,659	-381 Reduced 2.05%	18,169 $2.78 Million
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $2.44 Million - $3.03 Million	18,494 Added 33025.0%	18,550 $3.01 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $1.79 Million - $2.26 Million	-16,626 Reduced 99.66%	56 $7,000
Q3 2021 Nov 24, 2021	SELL	$106.4 - $120.78 $118,423 - $134,428	-1,113 Reduced 6.25%	16,682 $1.8 Million
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $167,580 - $190,228	1,575 Added 9.71%	17,795 $1.92 Million
Q2 2021 Nov 24, 2021	SELL	$105.21 - $117.21 $103,316 - $115,100	-982 Reduced 5.71%	16,220 $1.83 Million
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $114,152 - $127,172	1,085 Added 6.73%	17,202 $1.94 Million
Q1 2021 Nov 24, 2021	SELL	$102.3 - $112.62 $243,678 - $268,260	-2,382 Reduced 12.88%	16,117 $1.74 Million
Q1 2021 Apr 15, 2021	BUY	$102.3 - $112.62 $260,251 - $286,505	2,544 Added 15.94%	18,499 $2 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $1.28 Million - $1.73 Million	15,955 New	15,955 $1.71 Million

Others Institutions Holding ABBV

# of Institutions

4,078

Shares Held

1.28B

Call Options Held

16.9M

Put Options Held

15.1M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcdonald Partners LLC with notifications on news.

Account

Mcdonald Partners LLC Abb Vie Inc. Transaction History